These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33145888)

  • 1. Patient reported experience of the burden of neuroendocrine tumors and impact of eSHINE Patient Support Program on patient quality of life.
    Wakelin K
    Asia Pac J Clin Oncol; 2020 Nov; 16 Suppl 7():3-8. PubMed ID: 33145888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey.
    Leyden J; Pavlakis N; Chan D; Michael M; Clarke S; Khasraw M; Price T
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):256-263. PubMed ID: 29105989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours.
    Beesley VL; Burge M; Dumbrava M; Callum J; Neale RE; Wyld DK
    Support Care Cancer; 2018 Sep; 26(9):3153-3161. PubMed ID: 29594486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population-Based Analysis of Prospective Patient-Reported Outcomes.
    Hallet J; Davis LE; Mahar AL; Law CHL; Isenberg-Grzeda E; Bubis LD; Singh S; Myrehaug S; Zhao H; Beyfuss K; Moody L; Coburn NG
    Oncologist; 2019 Oct; 24(10):1384-1394. PubMed ID: 31270268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [177Lu-DOTA0,Tyr3]octreotate.
    Khan S; Krenning EP; van Essen M; Kam BL; Teunissen JJ; Kwekkeboom DJ
    J Nucl Med; 2011 Sep; 52(9):1361-8. PubMed ID: 21795361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do specialist youth cancer services meet the physical, psychological and social needs of adolescents and young adults? A cross sectional study.
    Bradford N; Walker R; Cashion C; Henney R; Yates P
    Eur J Oncol Nurs; 2020 Feb; 44():101709. PubMed ID: 31837593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden.
    Pearman TP; Beaumont JL; Cella D; Neary MP; Yao J
    Support Care Cancer; 2016 Sep; 24(9):3695-703. PubMed ID: 27029477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.
    Wolin EM; Leyden J; Goldstein G; Kolarova T; Hollander R; Warner RRP
    Pancreas; 2017; 46(5):639-647. PubMed ID: 28328615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Norfolk quality of life tool for assessing patients with neuroendocrine tumors.
    Vinik E; Carlton CA; Silva MP; Vinik AI
    Pancreas; 2009 Apr; 38(3):e87-95. PubMed ID: 19276865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between general self-efficacy, social support, cancer-related stress and physical health-related quality of life: a path model study in patients with neuroendocrine tumors.
    Haugland T; Wahl AK; Hofoss D; DeVon HA
    Health Qual Life Outcomes; 2016 Jan; 14():11. PubMed ID: 26787226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms, Psychosocial Factors, and Health-Related Quality of Life in Patients With Neuroendocrine Tumors: An Integrative Review.
    Haugland T; DeVon HA
    Cancer Nurs; 2019; 42(4):E36-E46. PubMed ID: 29846192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living With Neuroendocrine Tumors: Assessment of Quality of Life Through a Mobile Application.
    Adams JR; Ray D; Willmon R; Pulgar S; Dasari A
    JCO Clin Cancer Inform; 2019 Jul; 3():1-10. PubMed ID: 31283354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).
    Benavent M; Sastre J; Escobar IG; Segura A; Capdevila J; Carmona A; Sevilla I; Alonso T; Crespo G; García L; Canal N; de la Cruz G; Gallego J
    Health Qual Life Outcomes; 2021 Jan; 19(1):38. PubMed ID: 33516211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours.
    Sorbye H; Meyer LS; Mordal KE; Myhre S; Thiis-Evensen E
    Health Qual Life Outcomes; 2020 Jun; 18(1):188. PubMed ID: 32546236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis.
    Guccione L; Gough K; Drosdowsky A; Price T; Pavlakis N; Wyld D; Ransom D; Michael M; Schofield P
    Patient Educ Couns; 2022 Jan; 105(1):212-220. PubMed ID: 34030927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Defined Goals and Preferences Among Adults With Advanced Neuroendocrine Tumors.
    Li D; Sun CL; Kim H; Crook C; Zhang YH; Allen R; Ballena R; Hyder S; Koczywas M; Chung V; Lim D; Katheria V; Dale W; Singh G
    J Natl Compr Canc Netw; 2022 Dec; 20(12):1330-1337.e3. PubMed ID: 36509069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient experiences of having a neuroendocrine tumour: a qualitative study.
    Feinberg Y; Law C; Singh S; Wright FC
    Eur J Oncol Nurs; 2013 Oct; 17(5):541-5. PubMed ID: 23522828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom Burden at the End of Life for Neuroendocrine Tumors: An Analysis of 2579 Prospectively Collected Patient-Reported Outcomes.
    Hallet J; Davis LE; Mahar AL; Isenberg-Grzeda E; Bubis LD; Myrehaug S; Zhao H; Beyfuss K; Moody L; Law CHL; Coburn NG
    Ann Surg Oncol; 2019 Sep; 26(9):2711-2721. PubMed ID: 31147993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.
    Singh S; Granberg D; Wolin E; Warner R; Sissons M; Kolarova T; Goldstein G; Pavel M; Öberg K; Leyden J
    J Glob Oncol; 2017 Feb; 3(1):43-53. PubMed ID: 28717741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population.
    Beaumont JL; Cella D; Phan AT; Choi S; Liu Z; Yao JC
    Pancreas; 2012 Apr; 41(3):461-6. PubMed ID: 22422138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.